MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
60.91
-1.13
-1.81%
Opening 13:54 05/29 EDT
OPEN
61.50
PREV CLOSE
62.03
HIGH
62.30
LOW
60.66
VOLUME
441.79K
TURNOVER
--
52 WEEK HIGH
63.46
52 WEEK LOW
11.85
MARKET CAP
5.42B
P/E (TTM)
373.42
1D
5D
1M
3M
1Y
5Y
1D
Liquidia CEO Roger Jeffs disposes of 6,428 common shares valued at $399,716.32
PUBT · 21h ago
Liquidia is the best performing healthcare stock in the past month
Seeking Alpha · 1d ago
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy
NASDAQ · 2d ago
Liquidia to Present at Jefferies Global Healthcare Conference in Fireside Chat
PUBT · 2d ago
Major Insider Move at Liquidia Technologies Shakes Up Investor Watchlists
TipRanks · 2d ago
Liquidia CEO Roger Jeffs reports sale of common shares worth $4.58 million
PUBT · 2d ago
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
NASDAQ · 4d ago
CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity
NASDAQ · 4d ago
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.